Bank of Montreal
ORIC icon

Bank of Montreal’s Oric Pharmaceuticals ORIC Stock Holding History

Bank of Montreal’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-107,688
Closed -$636K – 4073
2022
Q4 		$636K Buy
+107,688
New +$364K ﹤0.01% 2467
2022
Q3 		– Sell
-38,788
Closed -$189 – 4337
2022
Q2 		$189 Buy
+38,788
New +$155K ﹤0.01% 3291
2021
Q2 		– Sell
-691
Closed -$16K – 4572
2021
Q1 		$16K Sell
691
-2,764
-80% -$87.3K ﹤0.01% 4152
2020
Q4 		$110K Buy
3,455
+3,052
+757% +$87.6K ﹤0.01% 3535
2020
Q3 		$10K Sell
403
-292
-42% -$6.95K ﹤0.01% 4133
2020
Q2 		$17K Buy
+695
New +$22.2K ﹤0.01% 3921

Other funds holding ORIC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Bank of Montreal's ORIC Position: Q1 2023 in Review

Bank of Montreal sold out of Oric Pharmaceuticals (ORIC) in Q1 2023, closing a stake of 107,688 shares — an estimated $636K sold.

Bank of Montreal first reported a position in ORIC in Q2 2020 and held it in 6 quarters. The position peaked at $636K in Q4 2022. 70 funds tracked by Wall St. Rank hold ORIC as of Q1 2023.

  • Bank of Montreal reported no remaining Oric Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • Bank of Montreal sold 107,688 Oric Pharmaceuticals shares in Q1 2023, an estimated $636K.
  • Bank of Montreal first reported a position in Oric Pharmaceuticals in Q2 2020 and held it in 6 quarters.
  • Bank of Montreal's Oric Pharmaceuticals position peaked at $636K in Q4 2022.
  • 70 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q1 2023.

Based on Bank of Montreal's 13F filing for Q1 2023, filed 13 Jun 2024.